Health X Platform logo

Health X Platform share news, announcements and annual reports

NSE: HEALTHXBSE: 533259Healthcare ServicesSmall Cap

Health X Platform Limited · Formerly Sastasundar Ventures · Face value ₹10 · Listed Oct 2010
Last close ₹289.50up ₹10.30 (3.69%)BSE ₹273.00

Share price at the NSE close on 30 Oct 2026. Previous close ₹279.20.

30 Oct: open ₹282.00, high ₹292.75, low ₹274.95

52-week range of traded prices to 30 Oct 2026
₹252.50Low, 30 Mar 2026₹363.00High, 13 Jan 2026
Market cap
₹921 Cr1,526th largest listed
P/E
Lossover the last 12 months
P/B
1.44
Dividend yield
Nonein the last 12 months
ROE
−3.1%
ROCE
−9.4%
Debt to equity
0.03
Volume, NSE
4,52679.6% delivered

Health X Platform board meetings

113 filed, newest first. Page 2 of 3.

  1. Feb 2021

  2. Nov 2020

  3. Aug 2020

  4. Jun 2020

  5. Feb 2020

  6. Dec 2019

  7. Sep 2019

  8. May 2019

  9. Feb 2019

  10. Jan 2019

  11. Oct 2018

  12. Aug 2018

  13. May 2018

  14. Jan 2018

  15. Nov 2017

  16. Aug 2017

  17. Jul 2017

  18. May 2017

  19. Feb 2017

  20. Jan 2017

  21. Dec 2016

  22. Nov 2016

  23. Oct 2016

  24. Jul 2016

  25. May 2016

  26. Apr 2016

  27. Feb 2016

  28. Jan 2016

  29. Oct 2015

  30. Aug 2015

  31. Jul 2015

  32. Jun 2015

  33. May 2015

  34. Jan 2015

  35. Nov 2014

    • 4 Nov · Board meeting

      To consider Inter alia the Un-Audited standalone and consolidated Financial Results of the Company for the Quarter and half year ended on September 30, 2014.
  36. Aug 2014

    • 5 Aug · Board meeting

      Inter alia, to consider the Un-Audited standalone and consolidated Financial Results of the Company for the First Quarter ended on June 30, 2014. Further, Pursuant to the provisions of Clause 36 of the Listing Agreement with the Stock Exchanges and in view of the declaration of the Unaudited Financial Results for the quarter ended June 30, 2014, the Trading Window under the Company's Code of Conduct for Prevention of Insider Trading" shall remain closed for dealing in shares of the Company for the Designated Employees defined in the code from August 4, 2014 to August 14, 2014 (both days inclusive).
  37. May 2014

    • 9 May · Board meeting

      Inter-alia to consider and approve the Audited Financial Results of the Company for the financial year ended on March 31, 2014.
  38. Feb 2014

    • 3 Feb · Board meeting

      To consider inter-alia the Un-Audited standalone and consolidated Financial Results of the Company for the Third Quarter ended on December 31, 2013.
  39. Nov 2013

    • 5 Nov · Board meeting

      To consider inter-alia the Un-Audited standalone and consolidated Financial Results of the Company for the Second Quarter ended on September 30, 2013.